Esters of 3'-deaminodoxorubicin and liposomal compositions thereof
US5132290A · kind A · utility
7Cited by
29References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 1989 |
| Grant date | Jul 21, 1992 |
| Priority date | — |
| Expiry date | May 30, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/207
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Three'-deaminodoxorubicin esters have been found to have excellent encapsulization efficiency in liposomes and to display high antineoplastic activity. The liposomal formulations have also been found to be quite stable.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.